HealthEquity, Inc. (NASDAQ:HQY – Get Rating) Director Gayle Furgurson Wellborn sold 5,237 shares of the company’s stock in a transaction on Wednesday, December 14th. The stock was sold at an average price of $62.00, for a total value of $324,694.00. Following the transaction, the director now directly owns 12,023 shares in the company, valued at $745,426. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.HealthEquity (NASDAQ:HQY) will be releasing earnings on Tuesday, December 6, Yahoo Finance reports.November saw a sharp decline in short interest for HealthEquity, Inc. (NASDAQ: HQY). Three million one hundred twenty thousand shares totaled short.

HealthEquity, Inc. (NASDAQ:HQY – Get Rating) was the target of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 3,120,000 shares, a decline of 12.1% from the October 31st total of 3,550,000 shares. Based on an average daily trading volume, of 848,200 shares, the short-interest ratio is presently 3.7 days. Approximately 3.8% of the shares of the company are sold short.According to Bloomberg, the nine analysts who are presently following Taylor Morrison Home Co. (NYSE: TMHC) have currently given the stock a rating that. Researching HealthEquity? Get The Latest HQY Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.According to Bloomberg, the sixteen rating agencies that cover HealthEquity, Inc. (NASDAQ: HQY) have given the stock an average rating of “Moderate Buy,”.

The price target for HealthEquity (NASDAQ:HQY) has been raised to $67.00.

In a research note distributed to investors on Wednesday, stock analysts at Robert W. Baird increased HealthEquity’s (NASDAQ: HQY) price objective from. The executive vice president of HealthEquity, Inc., Larry L. Trittschuh, sold 11,526 shares of the company’s stock (NASDAQ: HQY) on October 13 for a total. Researching HealthEquity? Get The Latest HQY Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.Researching Phreesia? Get The Latest PHR Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Researching The Ensign Group? Get The Latest ENSG Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.Eagle Bay Advisors LLC lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY – Get Rating) by 137.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,108 shares of the company’s stock after purchasing an additional 642 shares during the period. Eagle. . UBS Group AG grew its stake in HealthEquity, Inc. (NASDAQ:HQY – Get Rating) by 100.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 66,033 shares of the company’s stock after purchasing an additional 33,125 shares during the period. UBS Group. . Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

MarketBeat: Stock Market News and Research Tools

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Celsius Holdings, Inc. (NASDAQ:CELH – Get Rating) has earned a consensus rating of “Moderate Buy” from the eight analysts that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month target price among. .

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.Definitive Healthcare Corp. (NASDAQ:DH – Get Rating) gapped up prior to trading on Wednesday . The stock had previously closed at $11.65, but opened at $11.98. Definitive Healthcare shares last traded at $11.77, with a volume of 371 shares. Analyst Upgrades and Downgrades Several equities analysts have issued reports on DH shares. Needham & Company. .